Rheumatology clinical trials
We know the challenges of recruiting and enrolling patients for rheumatology clinical trials: complex protocols, difficulties finding increasingly niche patient populations, intense competition, a need for specialist expertise and requirement for infusions of biologic therapies.
Tough challenges demand innovative solutions
At the core of our solution is our understanding of, and access to, the patients you seek. Our database of 100 million households includes hundreds of thousands of patients with immunology and rheumatology conditions. We know who they are, where to find them, their preferences, and how to provide them with a superior clinical trial experience.
Add to this our rheumatology team’s vast clinical trial experience, a mature network of rheumatologists and other specialists who provide patient referrals and serve as investigators or consultants when needed. Our pre-screening platform can deliver the scale needed to find qualified patients that meet the increasingly narrow inclusion/exclusion criteria that often characterize these trials.
Example indication: rheumatoid arthritis (RA)
The traditional recruitment model of relying on sites to find patients with inflammatory arthritis is ill-equipped to meet the needs of most trials – and is particularly ineffective for RA trials where the demand for increasingly specific patient sub-populations is outpacing the supply.
When we employ our solutions for RA studies, we also bring to bear our resources, experience and expertise developed specifically for this indication.
Potential patients in database